<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer Milan</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6854770</article-id><article-id pub-id-type="publisher-id">1057</article-id><article-id pub-id-type="doi">10.1186/s10194-019-1057-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Association of diet and headache</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Razeghi Jahromi</surname><given-names>Soodeh</given-names></name><address><email>razeghi@sina.tums.ac.ir</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ghorbani</surname><given-names>Zeinab</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Martelletti</surname><given-names>Paolo</given-names></name><address><email>paolo.martelletti@uniroma1.it</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lampl</surname><given-names>Christian</given-names></name><address><email>christian.lampl@ordensklinikum.at</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9368-6835</contrib-id><name><surname>Togha</surname><given-names>Mansoureh</given-names></name><address><email>toghae@sina.tums.ac.ir</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><collab>On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)</collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411600.2</institution-id><institution>Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, </institution><institution>Shahid Beheshti University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution>Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, </institution><institution>Tehran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0571 1549</institution-id><institution-id institution-id-type="GRID">grid.411874.f</institution-id><institution>Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, </institution><institution>Guilan University of Medical Sciences, </institution></institution-wrap>Rasht, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7841.a</institution-id><institution>Department of Clinical and Molecular Medicine, </institution><institution>Sapienza University of Rome, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff5"><label>5</label>Headache Medical Center, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution>Headache Department, Neurology Ward, Sina University Hospital, School of Medicine, </institution><institution>Tehran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>20</volume><issue>1</issue><elocation-id>106</elocation-id><history><date date-type="received"><day>1</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The global prevalence of migraine as a primary headache has been estimated as 14.4% in both sexes. Migraine headache has been ranked as the highest contributor to disability in under 50&#x02009;years old population in the world. Extensive research has been conducted in order to clarify the pathological mechanisms of migraine. Although uncertainties remains, it has been indicated that vascular dysfunction, cortical spreading depression (CSD), activation of the trigeminovascular pathway, pro-inflammatory and oxidative state may play a putative role in migraine pain generation. Knowledge about pathophysiological mechanisms of migraine should be integrated into a multimodal treatment approach to increase quality of life in patients. With respect to this, within the integrative health studies growing interest pertains to dietary interventions. Although the number of studies concerning effects of diet on headache/migraine is not yet very large, the current article will review the available evidence in this area. All publications on headache/migraine and dietary interventions up to May 2019 were included in the present review through a PubMed/MEDLINE and ScienceDirect database search. According to the current findings, Ketogenic diet and modified Atkins diet are thought to play a role in neuroprotection, improving mitochondrial function and energy metabolism, compensating serotoninergic dysfunction, decreasing calcitonin gene-related peptide (CGRP) level and suppressing neuro-inflammation. It can also be speculated that prescription of low glycemic diet may be promising in headache/migraine control through attenuating the inflammatory state. Moreover, obesity and headaches including migraine could be attributed to each other through mechanisms like inflammation, and irregular hypothalamic function. Thereby, applying dietary strategies for weight loss may also ameliorate headache/migraine. Another important dietary intervention that might be effective in headache/migraine improvement is related to balance between the intake of essential fatty acids, omega-6 and omega-3 which also affect inflammatory responses, platelet function and regulation of vascular tone. Regarding elimination diets, it appears that targeted these diets in migraine patients with food sensitivities could be effective in headache/migraine prevention. Taken together, dietary approaches that could be considered as effective strategies in headache/migraine prophylaxis include weight loss diets in obese headache patients, ketogenic and low-calorie diets, reducing omega-6 and increasing omega-3 fatty acid intakes.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Migraine</kwd><kwd>Diet</kwd><kwd>Nutrition</kwd><kwd>Fasting</kwd><kwd>Elimination diet</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><sec id="Sec2"><title>Headache epidemiology and etiology</title><p id="Par31">According to the reports of global burden of headache, 2016 [<xref ref-type="bibr" rid="CR1">1</xref>], The global prevalence of migraine as a primary headache has been estimated as 14.4% in both sexes [<xref ref-type="bibr" rid="CR1">1</xref>]. Migraine headache has been ranked as the highest contributor to disability in under 50&#x02009;years old population in the world [<xref ref-type="bibr" rid="CR2">2</xref>]. Furthermore, it has been evident that women are affected by migraine 2 or 3 times more than men and also experience more disabling, more severe attacks with longer duration and increased risk of recurrent headaches [<xref ref-type="bibr" rid="CR3">3</xref>]. Based on the number of headache days in a month, migraine is classified into episodic migraine ((EM): having &#x0003c;&#x02009;15 headache days /month) or chronic migraine ((CM): having &#x02265;15 headache days /month with experiencing migraine features in at least 8&#x02009;days/month) [<xref ref-type="bibr" rid="CR4">4</xref>]. Suffering from concurrent disorders such as other neurologic and psychiatric disorders, chronic pain, cardiovascular diseases, gastrointestinal (GI) complaints, allergy or /asthma, and obesity would also make the treatment more complicated. These comorbidities may additionally be involved in the transformation from EM to CM [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Irrespective of treatment modalities applied, trigger control, and lifestyle modification are indispensable to the successful management of migraine [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par32">Therefore, knowledge about pathophysiological mechanisms of migraine should be integrated into a multimodal treatment approach to increase quality of life in patients. With respect to this, within the integrative health studies growing interest pertains to dietary interventions. Although the number of studies concerning effects of diet on headache/migraine is not yet very large, the current article will review the available evidence in this area. The dietary approaches that will be discussed throughout this manuscript include fasting and carbohydrate restricted diets (ketogenic diet (KD), low-calorie diet, modified Atkins diet (MAD), low glycemic diet (LGD),), weight loss diets, low-fat diet, elimination diet and low sodium diet. Afterwards, the possible mechanisms underlying each diet in protecting against primary headache with a focus on migraine pathogenies will be explored at the end of each section.</p></sec><sec id="Sec3"><title>Evidence acquisition</title><p id="Par33">All publications on headache/migraine and dietary interventions up to May 2019 were included in the present narrative review through a PubMed/MEDLINE, Science Direct and Google Scholar database search. The following keywords were used: &#x0201c;diet&#x0201d;, OR &#x0201c;nutrition&#x0201d;, OR &#x0201c;dietary intervention&#x0201d;, OR &#x0201c;ketosis&#x0201d;, OR &#x0201c;fasting&#x0201d;, OR &#x0201c;glycemic index&#x0201d;, OR &#x0201c;carbohydrate&#x0201d;, OR &#x0201c;fat&#x0201d;, OR &#x0201c;protein&#x0201d;, OR &#x0201c;weigh reduction&#x0201d;, OR &#x0201c;obesity&#x0201d;, OR &#x0201c;food elimination&#x0201d;, OR &#x0201c;sodium&#x0201d;, AND &#x0201c;chronic migraine&#x0201d;, OR &#x0201c;episodic migraine&#x0201d;, OR &#x0201c;tension type headache&#x0201d;, OR &#x0201c;headache&#x0201d;, OR &#x0201c;treatment&#x0201d; AND &#x0201c;inflammation&#x0201d;, &#x0201c;endothelial function&#x0201d;, OR &#x0201c;platelet aggregation&#x0201d;, OR &#x0201c;pain&#x0201d;, OR &#x0201c;nociception&#x0201d;. Reference of included articles was evaluated, and relevant studies were also included in the current review. All eligible studies were written in the English language and were performed on adults. A description of the studies on dietary interventions in adults with headache is summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref> and the studies on pediatric patients and adolescents are summarized in Additional file <xref rid="MOESM2" ref-type="media">2</xref>. The majority of included articles were case studies, case-series, case-control and clinical trials.</p></sec><sec id="Sec4"><title>Diet and headache</title><p id="Par34">Among lifestyle modalities, nutraceuticals and diet play a notable role in headache/migraine and therefore adjusting one&#x02019;s diet could be useful in preventing and treating headaches [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]. The main components of a comprehensive diet include carbohydrates, proteins, fats, vitamins, and ions. It is not clear whether these dietary factors prevent or provoke headache attacks [<xref ref-type="bibr" rid="CR11">11</xref>]. The initiation of a headache/migraine attack may occur following consumption of specific food items. These food items should be identified and eliminated [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Moreover, making specific dietary recommendations based on patients&#x02019; needs, and types of comorbidities could be effective in reducing the frequency of headache or even preventing initiation of an attack [<xref ref-type="bibr" rid="CR12">12</xref>]. The underlying comorbidities of the patients that have gained a special attention when making dietary advices consist of obesity, seizure, GI disorders, depression and anxiety, and food intolerance [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par35">So far, the effects of different types of diets have been studied in relation to migraine and headache [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. It is speculated that dietary interventions could affect headache/ migraine characteristics through a variety of mechanisms. These mechanisms may include affecting serotoninergic dysfunction, neuronal excitability, levels of factors with a role in migraine pathogenesis (such as Calctonin-Gene-Related-Peptide (CGRP), nitric oxide (NO), adiponectin, and leptin), brain mitochondrial function, neuro-inflammation, hypothalamic function, and platelet aggregation [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref>]. For example, obesity, which is highly related to western dietary patterns [<xref ref-type="bibr" rid="CR31">31</xref>], is also thought to be prevalent among headache patients [<xref ref-type="bibr" rid="CR32">32</xref>]. It has been proposed that headaches could be improved following reducing excessive weight [<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec></sec><sec id="Sec5"><title>Fasting and carbohydrate restricted diets</title><p id="Par36">Before long the great philosophers applied fasting as a means of therapy (<ext-link ext-link-type="uri" xlink:href="https://www.allaboutfasting.com/history-of-fasting.html">https://www.allaboutfasting.com/history-of-fasting.html</ext-link>). KD was initially designed in order to stimulate the ketotic effects of fasting. Using KD for treating refractory epilepsy dates back to the time of Hippocrates [<xref ref-type="bibr" rid="CR35">35</xref>]. Then after, in recent years it received growing attention as a potential treatment for other neurological disorders [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. In the following section, the effects of different types of fasting, low caloric, ketogenic, MAD and LGD on headache/migraine will be explored.</p><p id="Par37">In one case report and one case series [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], modified fasting was the mean of producing ketosis in headache patients. In the specific case report, a woman with chronic headache used modified fasting diet with 3&#x02013;4 high protein/low carbohydrate (200&#x02009;kcal) shake a day. After ketosis establishment, the headache attacks disappeared. This effect remained for 7 months after stopping fasting [<xref ref-type="bibr" rid="CR38">38</xref>]. In the mentioned case series study, 51 adults with chronic migraine followed a low-calorie diet (1200&#x02013;1500&#x02009;kcal/d) for several months. Significant reduction in headaches days and abortive medication consumption was observed. Twenty eight percent of the sample reached complete remission from migraine headache. Also, continuous improvement was noted for 3 months after stopping low calorie diet [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par38">Both KD and the MAD have been widely prescribed in the treatment of patients with intractable epilepsy [<xref ref-type="bibr" rid="CR15">15</xref>]. Carbohydrate content in KD is highly restricted which results in inducing fasting in addition to rapid weight loss and elevating metabolism of fat and thus producing ketone bodies (KB) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. While carbohydrate restriction in the MAD is lesser than KD, MAD does not require a prior induced fasting state, restriction of energy, protein or fluid and is thereby applied on out-patients [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Likewise to anticonvulsant medications, the beneficial effects of KD and MAD on the conditions such as neurodegenerative disorders, brain tumors, autism, amyotrophic lateral sclerosis, and migraine have also been of interest as a therapeutic strategy [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. These type of diets are thought to play a role in neuroprotection, mitochondrial function and enhancement of production of ATP [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par39">The application of KD for treating headache dates back to 1928 [<xref ref-type="bibr" rid="CR44">44</xref>]. In the first case-series, a group of 18 migraineurs treated with KD, half of the studied population reported some relief [<xref ref-type="bibr" rid="CR44">44</xref>]. Since then up to now, only a few case reports have addressed specifically the encouraging effect of KD on migraine/headache [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In a recent study [<xref ref-type="bibr" rid="CR40">40</xref>], 18 adults suffering from migraine without aura were investigated during interictal state. They were prescribed with KD for 1 month. Significant improvements were reported in frequency and duration of their migraine attacks. This could be explained by the fact that KD regulates the balance between inhibition and excitation at the cortical level as shown by normalizing the neurophysiologic tests findings including interictally decreased visual (VEPs) and median nerve somatosensory (SSEPs) evoked potentials habituation [<xref ref-type="bibr" rid="CR40">40</xref>]<underline>.</underline></p><sec id="Sec6"><title>Comparison of ketogenic and low-calorie diets</title><p id="Par40">Di Lorenzo and colleagues compared ketogenic and low-calorie (1200&#x02013;1500&#x02009;kcal/d) diets, in a group of 108 migraineurs [<xref ref-type="bibr" rid="CR14">14</xref>]. KD was superior to low-calorie diet with a 90% responder rate, while low calorie diet was not effective [<xref ref-type="bibr" rid="CR14">14</xref>]. Di Lorenzo et al. [<xref ref-type="bibr" rid="CR41">41</xref>] have additionally reported migraine remission following ketosis in an open-label study on 96 migraine suffers. During the ketogenic phase (the first month of intervention) in ketogenic very-low-calorie diet or KD group (<italic>n</italic>&#x02009;=&#x02009;45) a significant improvement in headache related features including frequency of attacks, number of headache days and medications use was demonstrated independent of weight reduction. Continuous improvement was also observed for a couple of months after stopping the diet. It is of note that although the frequency of headache days rapidly decreased in patients who followed KD, it worsened when they stopped the diet throughout the transition period (from first vs. second month of study). Moreover, there was a significant reduction in frequency of headache days and medications use and headache attacks frequency following prescribing an standard low-calorie diet in the other intervention group (<italic>n</italic>&#x02009;=&#x02009;51) after 3 and 6&#x02009;months, respectively [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec><sec id="Sec7"><title>Low glycemic diet (LGD)</title><p id="Par41">Consuming more than half of the total energy (50&#x02013;55%) from carbohydrate has been generally accepted as a healthy diet for several decades [<xref ref-type="bibr" rid="CR11">11</xref>]. In some circumstances such as epilepsy, weight management, diabetes, and hyperlipidemia, LGD has been proved as an effective alternative [<xref ref-type="bibr" rid="CR47">47</xref>]. In LGD, daily carbohydrate intake is restricted to 40&#x02013;60&#x02009;g with a glycemic index (GI) of less than 50 relative to glucose [<xref ref-type="bibr" rid="CR48">48</xref>]. So consumption of white bread, sugar, chocolate, sweets, pastries, rice, potato, corn, jams, honey, molasses, ready-made fruit juices, sugary carbohydrate drinks, watermelon, and melon would be limited [<xref ref-type="bibr" rid="CR49">49</xref>]. LGD is a therapeutic dietary option with remarkable advantages including its increased tolerability and a low incidence of side effects [<xref ref-type="bibr" rid="CR50">50</xref>]. In LGD carbohydrate is mainly come from legumes, vegetables, fruits, and high fiber cereals [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par42">In a RCT by Evcili et al. in 2018 [<xref ref-type="bibr" rid="CR49">49</xref>], 350 migraineurs were allocated (<italic>n</italic>&#x02009;=&#x02009;1:1) either to a low GI diet group or to a prophylactic medications group (who received propranolol, flunarazine, amitriptyline). One month after dietary restriction, frequency of attacks were reduced significantly in both groups. After 3 months, headache intensity was also significantly reduced following the low glycemic index diet [<xref ref-type="bibr" rid="CR49">49</xref>]. According to the results of different studies, LGD, at least in part, imposes its effect by modifying inflammatory responses. In a clinical study designed to evaluate the impacts of a low glycemic (GI 38) legume-enriched (250&#x02009;g/d) diet compared to a healthy American diet (GI 69), it was shown that soluble TNF-a receptors II and CRP levels were significantly attenuated by adherence to LGD [<xref ref-type="bibr" rid="CR51">51</xref>]. To summarize, it can be speculated that prescription of LGD may be promising in migraine control, However, more RCTs are required in order to fully elucidate the effects of LGD on migraine characteristics.</p></sec><sec id="Sec8"><title>Suggested mechanisms for the effects of ketosis on headache with a focus on migraine pathogenesis</title><p id="Par43">Despite several animal studies have been conducted on the effects of ketosis on different aspects of metabolism [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], the exact pathway by which it may affect on CSD, and trigeminal activation has not yet been clarified. However, several mechanisms have been proposed in the literature [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. According to in vitro research, it is thought that ketosis may attenuate the severity of migraine headache through compensating serotoninergic dysfunction, inhibition of neuronal excitability, decreasing CGRP synthesis and release, and cortical spreading depression (CSD) and by brain mitochondrial function improvement [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Moreover, studies on mouse models indicated that ketosis may prevent neurogenic inflammation [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] which is believed to play an important role in migraine pathogenesis [<xref ref-type="bibr" rid="CR28">28</xref>]. Also, animal studies revealed that ketosis might increase neuropeptide Y (NPY) and agouti-related protein (AgRP) levels through stimulating ghrelin secretion from the stomach during fasting state. It has been suggested that hypothalamic AgRP and NPY may reduce CGRP level subsequently [<xref ref-type="bibr" rid="CR55">55</xref>].</p></sec></sec><sec id="Sec9"><title>Weight loss strategies</title><p id="Par44">The relationship between primary headaches and obesity was first suggested by Scher and colleagues in 2003 [<xref ref-type="bibr" rid="CR56">56</xref>]. In a prospective population-based 11&#x02009;months follow-up, 3% of controls developed chronic daily headache (CDH). Obese subjects (body mass index (BMI)&#x02009;&#x02265;&#x02009;30), had a fivefold increase in the relative risk of developing CDH compared to normal weight individuals. Odds of CDH were three times higher in overweight patients (BMI: 25&#x02013;29) [<xref ref-type="bibr" rid="CR56">56</xref>]. In this regard, weight reduction is among the suggested interventions for headaches due to idiopathic intracranial hypertension [<xref ref-type="bibr" rid="CR33">33</xref>]. Although data about the effects of weight loss on primary headache control is limited, the association between migraine and obesity has been a growing field of interest in the recent years. According to an observational study, subjects with obesity would experience more frequent and severe headaches compared to normal-weight individuals [<xref ref-type="bibr" rid="CR34">34</xref>]. Besides, both abdominal and general obesity have been reported to be independent risk factors for headache development [<xref ref-type="bibr" rid="CR32">32</xref>]. Studies concerning the effects of weight reduction on migraine applied two approaches including non-surgical modalities, especially dietary intervention, or surgical approaches, particularly bariatric surgery [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. An open-label trial compared a low-calorie diet with KD found that achieving a significant weight loss through each of these interventions could result in a decrease of headache frequency [<xref ref-type="bibr" rid="CR41">41</xref>]. In a recent trial, bariatric surgery was compared with a multi-intervention approach including low-calorie diet and aerobic exercise program. With the comparable amount of weight loss, bariatric surgery offered a better improvement in headache days and attack duration than non-surgical interventions [<xref ref-type="bibr" rid="CR58">58</xref>]. Also, 2 observational studies [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] proposed a decrease in migraine intensity, frequency and disability in obese women suffered from migraine after bariatric surgery [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Indeed, these studies showed promising results [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. However, a recent small single blind trial examined the effect of low-calorie diet on migraine and found no significant effect [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par45">To conclude, although considerable efforts have been made in this field, the results about the direct effects of weight loss dietary intervention on migraine/headache are not conclusive yet. Differences in assessing and modifying life style parameters might influence the results of the studies on the effect of weight loss in controlling headache attacks. In the following part, the proposed mechanisms of the association between excess body weight and migraine will be discussed. Notwithstanding, when it comes to shared pathophysiological pathways, inflammation received most attention.</p><sec id="Sec10"><title>Migraine and metabolic syndrome</title><p id="Par46">In addition to obesity, hypertension, dyslipidemia, insulin resistance, and augmented inflammation, that all are believed to be components of metabolic syndrome, tend to be highly prevalent diseases in migraineurs [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Recent studies have reported that insulin level may also be higher among migraineurs. About 11.1% of these patients may suffer from IR [<xref ref-type="bibr" rid="CR61">61</xref>]. It was also noted that IR might correlate with attacks duration in migraine suffers [<xref ref-type="bibr" rid="CR62">62</xref>]. Migraine and metabolic syndrome are usually comorbid, though no causal relationship has yet been established [<xref ref-type="bibr" rid="CR60">60</xref>]. Moreover, the association between metabolic syndrome components and migraine characteristics including frequency of headache attacks, severity and duration needs further studies [<xref ref-type="bibr" rid="CR60">60</xref>]. Although no specific treatment for migraine and concurrent metabolic syndrome has been proposed to date, general recommendations are given on following a weight reduction plan including diet and physical activity, proper sleep duration, and reducing stress levels [<xref ref-type="bibr" rid="CR60">60</xref>].</p></sec><sec id="Sec11"><title>Suggested mechanisms for the association between obesity and headache with a focus on migraine pathogenesis</title><sec id="Sec12"><title>Three dimensional effect of inflammation, headache, and obesity</title><p id="Par47">The hypothetical relationship between obesity and migraine has been linked to an elevated release of pro-inflammatory markers and neuroinflammation that might be principally involved in migraine pain genesis [<xref ref-type="bibr" rid="CR28">28</xref>]. Among the studied proinflammatory agents, elevated level of C-reactive protein (CRP), which is known as a marker of systemic inflammation, has been reported both in obese individuals and patients with migraine. It seems there could be an epidemiological association between CRP and migraine headache onset [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Furthermore, a rise in pro-inflammatory factors, such as interleukin (IL)-1&#x003b2;, IL-6, tumor necrosis factor (TNF)-&#x003b1; and leptin were reported in obese individuals, while anti-inflammatory agents including adiponectin seem to be increased in this population. These events finally lead to a persistent low-grade inflammatory status [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. On the other aspect, IL-1&#x003b2;, IL-6, TNF-&#x003b1; levels have also been shown to be elevated in migraineurs especially during their attack phases [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref>].</p><p id="Par48">In addition, due to the important role of CGRP in migraine pathogenesis, the neuropeptide and its receptors are predominantly important targets for migraine treatment [<xref ref-type="bibr" rid="CR29">29</xref>]. On the other hand, evidence proposed an increase in plasma CGRP level in adults with obesity, which is also observed in patients with migraine [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Moreover, it has been proposed that the administration of CGRP induces the accumulation of fat in obese animal models. Also in murine model, an elevation of CGRP level was reported before obesity onset [<xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR73">73</xref>]. Substance P (SP) in another factor which is likely to play a role in migraine attack pathogenesis that was also detected in adipose tissue and shares a role in fat accumulation and the start of the inflammatory cascade related to obesity [<xref ref-type="bibr" rid="CR70">70</xref>].</p></sec><sec id="Sec13"><title>Adipokines and migraine</title><p id="Par49">Further, in recent years, the relationship between adipocytes released factors, known as adipokines (e.g. adiponectin and leptin) and migraine headache has given more insight into the contribution of adipose tissue in the pathophysiology of migraine [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Although more studies are required to make a definite conclusion, the current evidence propose that adiponectin concentration might be increased between attack phases whereas it may be decreased during migraine attacks [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. It has also been mentioned that the level of this factor might be mediated following prophylactic treatment of migraine with topiramate [<xref ref-type="bibr" rid="CR23">23</xref>]. Thus, it could be hypothesized that chronic rise in adiponectin level might be beneficial in migraine improvement [<xref ref-type="bibr" rid="CR23">23</xref>]. This issue might be related to the reported correlation of low level of adiponectin with proinflammatory cytokine secretion and platelet aggregation [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Adiponectin may block TNF-&#x003b1; and IL-6 production and on the other hand, it could induce IL-10 and IL-1 receptor antagonist (IL-1 RA) formation [<xref ref-type="bibr" rid="CR74">74</xref>]. Thus, at lower than normal levels, adiponectin might be nociceptive [<xref ref-type="bibr" rid="CR58">58</xref>]. On the other hand, reduced adiponectin level appears be involved in increasing the risk of developing obesity, atherosclerosis and diabetes [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Additionally, increased leptin level is thought to induce secretion of proinflammatory factors that play a role in migraine (IL-6 and TNF- &#x003b1;) and NO, through NF&#x003ba;&#x003b2; signaling pathway [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. The current findings reported leptin administration in Wistar rats could diminish the threshold of pain [<xref ref-type="bibr" rid="CR76">76</xref>]. On the flip side, enhancement of leptin levels following weight reduction has been noted [<xref ref-type="bibr" rid="CR23">23</xref>]. However, the results of the researches concerning the association between leptin levels and migraine have not been conclusive yet [<xref ref-type="bibr" rid="CR23">23</xref>]. Nonetheless, it is likely that migraineurs might have lower leptin levels in ictal phases and higher levels of leptin during inter attack periods. Besides, there may be a negative relationship between leptin and pain intensity [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec14"><title>Effect of irregular hypothalamic function on weight and headache</title><p id="Par50">Some neurotransmitters, such as serotonin (5HT), are responsible for food consumption and body weight regulation which are controlled by hypothalamus and seems to be involved in sense of fullness [<xref ref-type="bibr" rid="CR25">25</xref>]. On the other hand, the increment in serotonin concentrations in ictal periods in migraine can possibly be attributed to the secretion of serotonin from platelets that induce vasoconstriction of arteries and affects CSD development [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par51">Another appetite regulator, which also might be contributed to migraine, is orexin A. An increase in CSF level of orexin has been observed in migraineurs [<xref ref-type="bibr" rid="CR63">63</xref>]. Orexin A could have antinociceptive characteristic and may probably play a role in compensatory reaction to pain and also contribute to hunger perception [<xref ref-type="bibr" rid="CR63">63</xref>]. Additionally, orexinergic system dysfunction may be associated with homeostatic pathways which are involved in risk of attack generation, migraine nociception and characteristics, as well as its premonitory stage including appetite alteration [<xref ref-type="bibr" rid="CR77">77</xref>]. Evidence showed that orexin A administration in murine model stimulates hunger and postpones the sense of fullness [<xref ref-type="bibr" rid="CR63">63</xref>]. Therefore, applying the medications that can affect the orexinergic system may ameliorate migraine associated gastrointestinal features [<xref ref-type="bibr" rid="CR77">77</xref>]. However, more studies are needed in order to address the association between orexin A and migraine headache in obese and non-obese individuals and explore the effects of drugs that target this system in migraineurs.</p><p id="Par52">Besides, available data suggest that hypothalamic NPY may contribute to the etiology of weight gain among migraineurs who received prophylactic treatment [<xref ref-type="bibr" rid="CR77">77</xref>]. For instance, NPY concentrations in plasma of migraine suffers may be elevated following treatment with flunarizine or amitriptyline. It has been also proposed that the weight gain following drug therapy may probably be related to changes in leptin transport system or sensitivity to leptin [<xref ref-type="bibr" rid="CR77">77</xref>].</p></sec></sec></sec><sec id="Sec15"><title>Low-fat diet</title><p id="Par53">Five studies addressed the effect of low-fat diets as means of migraine/headache prophylaxis [<xref ref-type="bibr" rid="CR78">78</xref>&#x02013;<xref ref-type="bibr" rid="CR82">82</xref>]. In 1999, a trial conducted to assess the role of fat-reduced diet for migraine control in 54 adults. Patients were instructed to restrict their fat intake to less than 20&#x02009;g/d for 12&#x02009;weeks, after 28&#x02009;days of run-in period. They reported a notable reduction in headache frequency, intensity, and need for abortive medication [<xref ref-type="bibr" rid="CR78">78</xref>]. An open-label, randomized cross-over trial investigated the effect of a diet change in comparison with a placebo supplement on migraine patients. For the first 16-week duration, 42 individuals were randomly allocated in <underline>intervention group</underline> (who were prescribed a low-fat vegan diet for 4 weeks, followed by elimination diet for 4 weeks, followed by reintroduction diet for the last 8 weeks group, <italic>n</italic>&#x02009;=&#x02009;21) or <underline>placebo group</underline> (who were supplemented with 10 mcg alpha-linolenic acid +&#x02009;10 mcg vitamin E as placebo, <italic>n</italic>&#x02009;=&#x02009;21). Then after a 4-week washout period was considered and the studied subjects in either group crossed over to the other group. A decrease in headache intensity, frequency, and use of abortive medication were observed following the intervention; However, in the mentioned trial, details regarding dietary fat composition were not noted [<xref ref-type="bibr" rid="CR79">79</xref>]. In another cross-over study on 63 adults with episodic or chronic migraine, low lipid diet (&#x0003c;&#x02009;20% of total daily energy intake) for 3&#x02009;months significantly reduced frequency and severity of headache attacks. In this study, participants did not reduce total fat intake to less than 45&#x02009;g/d and used olive oil as the main source of fat intake [<xref ref-type="bibr" rid="CR80">80</xref>]. Additionally, based on the theory of the probable effects of different fat types on headache characteristics, a randomized study assessed the effect of omega-3 and omega-6 intake. Fifty-five adults with CM were either reduced omega-6 fats intake or reduced omega-6 fats along with increased omega-three consumption. After 12&#x02009;weeks, individuals on high omega-3 combined with low omega-6 diet showed a higher headache improvement compared to headache patients on the reduced omega-6 diet [<xref ref-type="bibr" rid="CR81">81</xref>]. In another randomized double-blind controlled trial on 80 patients with EM, effect of omega-3 supplementation (2500&#x02009;mg/d) was compared with either nano-curcumin (80&#x02009;mg/d) or placebo. After 2 months of supplementation, combination of nano-curcumin and &#x003c9;-3 fatty acids lowered the expression of TNF-&#x003b1; mRNA and serum level of TNF-&#x003b1;. Headache frequency was also reduced in all treatment groups (incl. Nano-curcumin, omega-3, and combination of omega-3/nano-curcumin), with two-fold higher effect in combination group [<xref ref-type="bibr" rid="CR82">82</xref>].</p><sec id="Sec16"><title>Suggested mechanisms for the association between dietary fat and headache with a focus on migraine pathogenesis</title><sec id="Sec17"><title>Fat intake, inflammation, hypercoagulability and hyperaggregability</title><p id="Par54">Amount and type of fat intake affect inflammatory responses [<xref ref-type="bibr" rid="CR16">16</xref>]. The balance between the omega-6 and omega-3, two main fatty acids that compete with arachidonic acid as eicosanoid biosynthesis precursor, contribute to inflammatory control in response to the environmental metabolic changes. Prostaglandins (PG), which are made from essential fatty acids, take part in platelet function and regulation of vascular tone. PGs also play the principal role in controlling acute and chronic inflammation [<xref ref-type="bibr" rid="CR16">16</xref>]. PGE1, downstream metabolite of linoleic acid (omega-6), is one of the most potent vasodilators. PGE1 has been shown to cause headache [<xref ref-type="bibr" rid="CR83">83</xref>]. On the other hand, omega-3 fatty acids (i.e. eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) might probably attenuate platelet aggregation [<xref ref-type="bibr" rid="CR84">84</xref>] and affect serotonin biosynthesis pathway or the function of 5HT receptors [<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par55">It is generally believed that high-fat diet elevates plasma LDL-cholesterol and consequently increases platelet agreeability [<xref ref-type="bibr" rid="CR86">86</xref>]. Studies reported hypercoagulation in serum samples obtained from healthy subjects after a high-fat meal [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. On the flip side, it has been suggested that migraine attack could be initiated following and condition that causes platelet aggregation, through serotonin secretion and its consequent effects on blood vessels, and NO and PGs production. The secretion of these factors simultaneously may contribute to head pain initiation in migraine [<xref ref-type="bibr" rid="CR88">88</xref>].</p><p id="Par56">In particular, it is proposed that vulnerability to migraine is likely to be related to constant low concentration of serum serotonin and increased sensitivity to serotonin agonists during attacks, probably due to a defect in serotonin metabolism [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. In this regard, suppressing platelet aggregation might have therapeutic value in migraine prevention [<xref ref-type="bibr" rid="CR88">88</xref>]. Therefore, any modalities in dietary fat intake that results in modulating plasma free fatty acids and plasma lipid profile and consequently reducing platelet aggregation, seems to decrease the frequency and duration of migraine headache [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR88">88</xref>].</p></sec></sec></sec><sec id="Sec18"><title>Elimination diet</title><p id="Par57">Each headache patients may have a specific trigger or a unique set of triggers. It is known that certain types of foods and beverages can act as headache triggers [<xref ref-type="bibr" rid="CR13">13</xref>]. Cheese, chocolate, citrus fruit, alcohol, coffee, tomatoes, carbohydrates, leavened products and red wine are among the proposed foods that may trigger migraine attacks [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. However, there is not any consensus between previous studies on identifying food triggers in headache. For example, as mentioned, chocolate have been introduced as one of triggering foods of headache; while a double-blind trial by Marcus et al. [<xref ref-type="bibr" rid="CR91">91</xref>] performed in order to assess the effects of chocolate compared to carob on 63 female subjects suffering from with chronic headache, yielded different results. The trial was conducted following prescribing a diet in which vasoactive amine-rich foods were restricted for 2&#x02009;weeks. However, after administration of chocolate and carob (both two samples), there was not any differences in provocative effects of these agents on headache [<xref ref-type="bibr" rid="CR91">91</xref>].</p><p id="Par58">Moreover, there has been speculation about the way that food triggers may act in migraine attack initiation and some probable mechanisms are proposed: the &#x02018;amine hypothesis&#x02019;, &#x0201c;allergic&#x0201d; mechanism or histamine/NO caused vasodilatation; though, none of these suggested mechanisms has yet been established by adequate evidence [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par59">In the following paragraphs, the studies regarding elimination diets in headache patients have been described. A few studies assessed the effect of elimination diets in controlling headache among adults. Two randomized controlled trials (RCT), applied the personalized method for eliminating trigger food in migraine suffers, using IgG antibodies to food antigens [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. Although, the 12-week parallel-group trial on patients with migraine like headaches that examined the impact of the elimination diet compared to a sham diet failed to show any differences between the 2 studied arms [<xref ref-type="bibr" rid="CR93">93</xref>], the other study demonstrated beneficial effects in reducing migraine headaches [<xref ref-type="bibr" rid="CR92">92</xref>]. In this research, the effect of the eliminating diet in migraineurs, who also suffered from irritable bowel syndrome was explored. It was reported that a diet excluding provocative foods in comparison with provocation diet could effectively attenuate the symptoms of both disorders with positive effects on patients quality of life [<xref ref-type="bibr" rid="CR92">92</xref>]. Similarly, a small cross-over RCT showed that individualized elimination diet could reduce migraine frequency and abortive medication need, compared to a standard diet after six-week [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par60">Some headache suffers report that specific foods only provoke headache in combination with stress or extended physical exercise. Both conditions are identified as headache triggers and lead to the production of proinflammatory cytokines [<xref ref-type="bibr" rid="CR18">18</xref>]. Therefore, it seems that applying elimination diets in headache patients with food sensitivities could be effective in preventing migraine attacks, though more studies are needed [<xref ref-type="bibr" rid="CR94">94</xref>].</p><p id="Par61">Some patients may also be sensitive to other triggers like histamine, which is related to impairment of detoxification caused by low activity of di-amino-oxidase. Histamine thus, may play an additional role which should be considered in the elimination diets [<xref ref-type="bibr" rid="CR18">18</xref>]. A sample of 28 patients who suffered from chronic headache attacks were assigned to complete a histamine-free diet for 4 weeks. Nineteen patients had a 50% or greater decline in their headache attacks. Also, the number of headache attacks and analgesic medication consumption significantly decreased following the histamine-free diet [<xref ref-type="bibr" rid="CR95">95</xref>].</p><p id="Par62">With respect to the probable link between migraine and allergy [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>], and due to the beneficial effects of histamine-reduced diet on histamine intolerance symptoms and allergic disorders [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>], it can be hypothesized that this type of diet might be promising in migraine control particularly among allergic patients.</p><sec id="Sec19"><title>Suggested mechanisms for the effects of elimination diet on headache with a focus on migraine pathogenesis</title><p id="Par63">The mechanisms of IgG-mediated food allergy have not been entirely clarified, but it has been suggested that an increase in production of pro-inflammatory mediators and IgG antibodies through food allergy reaction can induce an inflammatory state that may play a crucial role in the migraine pathophysiology [<xref ref-type="bibr" rid="CR92">92</xref>]. In both migraine and food sensitivities, inflammation induced by food could make the pro-inflammatory environment which is needed for the induction of headache by other triggers [<xref ref-type="bibr" rid="CR18">18</xref>]. In this regard, when we focus on inflammation caused by food, a specific indicator is required. Except for IgG4, all IgG subclasses can cause an inflammatory response in exposure to the respective antigen [<xref ref-type="bibr" rid="CR18">18</xref>]. Accordingly, specific IgG can thus be considered as an ideal tool for a vast number of foods to identify individually suspected food items and enables adjusting eating habits in order to prevent chronic inflammation and occurrence of migraine in sensitized patients [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec></sec><sec id="Sec20"><title>Low sodium diet</title><p id="Par64">According to the findings of a large sample population-based cohort study there might be a negative relationship between blood pressure and headache occurrence [<xref ref-type="bibr" rid="CR100">100</xref>].</p><p id="Par65">Therefore, it may be logical to anticipate that dietary interventions that reduce blood pressure, could also lower headache occurrence. In this regard, certain nutritional strategies for lowering blood pressure including dietary approach to stop hypertension (DASH) diet and controlling the amount of sodium intake [<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>], could be considered as a matter of interest in studies on headache prophylaxis. Available evidence on sodium intake in relation to headache has mainly focused on monosodium glutamate (MSG) intake on headache initiation [<xref ref-type="bibr" rid="CR103">103</xref>]. Otherwise, in a descriptive study on 266 women with migraine headache, severe headache (measured by visual analogue scale (VAS): 8&#x02013;10) was 46% less prevalent in subjects with the greatest adherence to the DASH diet. Also, the frequency of moderate headaches (VAS: 4&#x02013;7) was 36% lower in this group compared to the individuals with lowest adherence [<xref ref-type="bibr" rid="CR104">104</xref>]. However, the result of the only multicenter, randomized clinical trial on the effect of DASH and low-sodium diet on headache is to somehow different. The study was performed on 390 participants in three 30-days phases (i.e. 1: high sodium diet, 2: intermediate sodium diet and 3: low sodium diet in a random allocation). The occurrence of headaches was not different in DASH group compared to controls, following either phases of low, intermediate and high sodium diets. However, headache risk was lower in low versus high sodium intake, both in DASH diet and control groups [<xref ref-type="bibr" rid="CR105">105</xref>]. In sum, according to these findings, the current data on the effects of dietary sodium intakes on headache characteristic is not conclusive yet. Thereby, except for those migraineurs suffering from concurrent hypertension [<xref ref-type="bibr" rid="CR106">106</xref>], more researches are needed to be able to make certain advice for optimal sodium intake in migraine patients.</p><sec id="Sec21"><title>Suggested mechanisms for the effects of low sodium diet on headache</title><p id="Par66">Dietary sodium may aggregate headache attacks via direct influence on increasing blood pressure or through inducing endothelial dysfunction [<xref ref-type="bibr" rid="CR106">106</xref>]. However, due to lack of well-designed clinical trials, and according to the current findings, there is not a persuasive basis for probable beneficial effects of a low sodium diet on migraine. Thus, in vivo and in vitro animal studies and further well-designed clinical trials are needed to clarify the effects of dietary sodium on migraine/headache pathogenesis.</p></sec></sec><sec id="Sec22"><title>Conclusion</title><p id="Par67">According to the present review, different nutritional interventions might be effective in migraine and their associated symptoms. There are different types of diets that are thought to attenuate migraine headache. For example, KD and MAD might play a role in neuroprotection, mitochondrial function and energy metabolism, compensating serotoninergic dysfunction, decreasing CGRP level, suppressing neuro-inflammation and CSD, all may be involved in the pathophysiology of migraine. It can also be speculated that prescription of low glycemic diet may be promising in headache/migraine control through attenuating the inflammatory state. Moreover, obesity and headaches especially migraine could be attributed to each other through mechanisms like inflammation, and irregular hypothalamic function. Thereby, applying dietary strategies for weight loss may also ameliorate headache/migraine. Another important dietary intervention that might be effective in headache/migraine improvement is related to balance between the intake of essential fatty acids, omega-6 and omega-3. These dietary approaches could affect inflammatory responses, platelet function and regulation of vascular tone. Regarding elimination diet, it could mostly be effective in migraine patients with food sensitivities to prevent the headaches.</p><p id="Par68">Because in some sections it was not possible to differentiate headache and migraine in included articles, and given there is a dearth of rigorous RCTs in the field of diet and migraine, the results of present review should be should be completed by the future studies. Taken together, dietary approaches that could be considered as effective strategies in headache/migraine prophylaxis include weight loss diets in obese headache patients, ketogenic and low-calorie diets, reducing omega-6 and increasing omega-3 fatty acid intakes.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec23"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10194_2019_1057_MOESM1_ESM.docx"><caption><p><bold>Additional file 1:Table S1.</bold> A description of the studies on dietary interventions in adults with headache.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="10194_2019_1057_MOESM2_ESM.docx"><caption><p><bold>Additional file 2:Table S2</bold>. A description of the studies on dietary interventions in children and adolescents with headache.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>5HT</term><def><p id="Par2">Serotonin</p></def></def-item><def-item><term>AgRP</term><def><p id="Par3">Agouti-related protein</p></def></def-item><def-item><term>BMI</term><def><p id="Par4">BMI body mass index</p></def></def-item><def-item><term>CDH</term><def><p id="Par5">Chronic daily headache</p></def></def-item><def-item><term>CGRP</term><def><p id="Par6">Calctonin-Gene-Related-Peptide</p></def></def-item><def-item><term>CM</term><def><p id="Par7">Chronic migraine</p></def></def-item><def-item><term>CRP</term><def><p id="Par8">C-reactive protein</p></def></def-item><def-item><term>CSD</term><def><p id="Par9">Cortical spreading depression</p></def></def-item><def-item><term>DASH</term><def><p id="Par10">Dietary approach to stop hypertension</p></def></def-item><def-item><term>EM</term><def><p id="Par11">Episodic migraine</p></def></def-item><def-item><term>GI</term><def><p id="Par12">Glycemic index</p></def></def-item><def-item><term>IL</term><def><p id="Par13">Interleukin</p></def></def-item><def-item><term>KD</term><def><p id="Par14">Ketogenic diets</p></def></def-item><def-item><term>LGD</term><def><p id="Par15">Low glycemic diet</p></def></def-item><def-item><term>MAD</term><def><p id="Par16">Modified Atkins diet</p></def></def-item><def-item><term>MDA</term><def><p id="Par17">Malondialdehyde</p></def></def-item><def-item><term>MSG</term><def><p id="Par18">Monosodium glutamate</p></def></def-item><def-item><term>NO</term><def><p id="Par19">Nitric oxide</p></def></def-item><def-item><term>NPY</term><def><p id="Par20">Neuropeptide Y</p></def></def-item><def-item><term>ORAC</term><def><p id="Par21">Oxygen radical absorbance capacity</p></def></def-item><def-item><term>PG</term><def><p id="Par22">Prostaglandin</p></def></def-item><def-item><term>PPAR&#x003b1;</term><def><p id="Par23">Peroxisome proliferator-activated receptor</p></def></def-item><def-item><term>RCT</term><def><p id="Par24">Randomized controlled trials</p></def></def-item><def-item><term>ROS</term><def><p id="Par25">Reactive Oxygen Sepsis</p></def></def-item><def-item><term>SP</term><def><p id="Par26">Substance P</p></def></def-item><def-item><term>TBARS</term><def><p id="Par27">Thiobarbituric acid reactive substances</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p id="Par28">Tumor necrosis factor-&#x003b1;</p></def></def-item><def-item><term>TOS</term><def><p id="Par29">Total oxidant status</p></def></def-item><def-item><term>VAS</term><def><p id="Par30">Visual analogue scale</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Soodeh Razeghi Jahromi, Zeinab Ghorbani, Paolo Martelletti, Christian Lampl and Mansoureh Togha contributed equally to this work.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s10194-019-1057-1.</p></sec><ack><title>Acknowledgements</title><p>Authors thank Dr. Samaneh Haghighi the scientific secretary of the 6th EHF-SAS and Ms. Francesca Romana Britti for helping in coordination of the 6th EHF-SAS in Iran.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>All authors contributed equally. SRJ and ZGh are junior fellows, while PM, CL, and MT are senior fellows of EHF-SAS. All authors contributed with data interpretation, drafting, revision of the manuscript and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All included references in the present review article are available on the Internet.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par69">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par70">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par71">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stovner</surname><given-names>LJ</given-names></name><name><surname>Nichols</surname><given-names>E</given-names></name><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>Abd-Allah</surname><given-names>F</given-names></name><name><surname>Abdelalim</surname><given-names>A</given-names></name><name><surname>Al-Raddadi</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Global, regional, and national burden of migraine and tension-type headache, 1990&#x02013;2016: a systematic analysis for the global burden of disease study 2016</article-title><source>Lancet Neurol</source><year>2018</year><volume>17</volume><issue>11</issue><fpage>954</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(18)30322-3</pub-id><pub-id pub-id-type="pmid">30353868</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>Stovner</surname><given-names>LJ</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Jensen</surname><given-names>R</given-names></name><name><surname>Katsarava</surname><given-names>Z</given-names></name></person-group><article-title>Migraine is first cause of disability in under 50s: will health politicians now take notice?</article-title><source>J Headache Pain</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/s10194-018-0846-2</pub-id><?supplied-pmid 29468450?><pub-id pub-id-type="pmid">29468450</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetvik</surname><given-names>KG</given-names></name><name><surname>MacGregor</surname><given-names>EA</given-names></name></person-group><article-title>Sex differences in the epidemiology, clinical features, and pathophysiology of migraine</article-title><source>Lancet Neurol</source><year>2017</year><volume>16</volume><issue>1</issue><fpage>76</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(16)30293-9</pub-id><?supplied-pmid 27836433?><pub-id pub-id-type="pmid">27836433</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd. Cephalalgia. 2018;38(1):1&#x02013;211. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/29368949">https://www.ncbi.nlm.nih.gov/pubmed/29368949</ext-link>.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>A</given-names></name><name><surname>Schulte</surname><given-names>LH</given-names></name></person-group><article-title>Chronic migraine: risk factors, mechanisms and treatment</article-title><source>Nat Rev Neurol</source><year>2016</year><volume>12</volume><issue>8</issue><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.93</pub-id><?supplied-pmid 27389092?><pub-id pub-id-type="pmid">27389092</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martami</surname><given-names>F</given-names></name><name><surname>Ghorbani</surname><given-names>Z</given-names></name><name><surname>Abolhasani</surname><given-names>M</given-names></name><name><surname>Togha</surname><given-names>M</given-names></name><name><surname>Meysamie</surname><given-names>A</given-names></name><name><surname>Sharifi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran</article-title><source>Neurol Sci</source><year>2018</year><volume>39</volume><issue>1</issue><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s10072-017-3141-0</pub-id><?supplied-pmid 29022143?><pub-id pub-id-type="pmid">29022143</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>PR</given-names></name></person-group><article-title>Behavioral management of migraine headache triggers: learning to cope with triggers</article-title><source>Curr Pain Headache Rep</source><year>2010</year><volume>14</volume><issue>3</issue><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1007/s11916-010-0112-z</pub-id><?supplied-pmid 20425190?><pub-id pub-id-type="pmid">20425190</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Onofrio</surname><given-names>F</given-names></name><name><surname>Raimo</surname><given-names>S</given-names></name><name><surname>Spitaleri</surname><given-names>D</given-names></name><name><surname>Casucci</surname><given-names>G</given-names></name><name><surname>Bussone</surname><given-names>G</given-names></name></person-group><article-title>Usefulness of nutraceuticals in migraine prophylaxis</article-title><source>Neurol Sci</source><year>2017</year><volume>38</volume><issue>Suppl 1</issue><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s10072-017-2901-1</pub-id><?supplied-pmid 28527067?><pub-id pub-id-type="pmid">28527067</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaik</surname><given-names>MM</given-names></name><name><surname>Gan</surname><given-names>SH</given-names></name></person-group><article-title>Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine</article-title><source>Biomed Res Int</source><year>2015</year><volume>2015</volume><fpage>469529</fpage><?supplied-pmid 25815319?><pub-id pub-id-type="pmid">25815319</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferroni</surname><given-names>P</given-names></name><name><surname>Barbanti</surname><given-names>P</given-names></name><name><surname>Della-Morte</surname><given-names>D</given-names></name><name><surname>Palmirotta</surname><given-names>R</given-names></name><name><surname>Jirillo</surname><given-names>E</given-names></name><name><surname>Guadagni</surname><given-names>F</given-names></name></person-group><article-title>Redox mechanisms in migraine: novel therapeutics and dietary interventions</article-title><source>Antioxid Redox Signal</source><year>2018</year><volume>28</volume><issue>12</issue><fpage>1144</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1089/ars.2017.7260</pub-id><?supplied-pmid 28990418?><pub-id pub-id-type="pmid">28990418</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trumbo</surname><given-names>P</given-names></name><name><surname>Schlicker</surname><given-names>S</given-names></name><name><surname>Yates</surname><given-names>AA</given-names></name><name><surname>Poos</surname><given-names>M</given-names></name></person-group><article-title>Dietary reference intakes for energy, carbohydrate, Fiber, fat, fatty acids, cholesterol, protein and amino acids</article-title><source>J Acad Nutr Diet</source><year>2002</year><volume>102</volume><issue>11</issue><fpage>1621</fpage><lpage>1630</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>VT</given-names></name><name><surname>Vij</surname><given-names>B</given-names></name></person-group><article-title>Diet and headache: part 2</article-title><source>Headache</source><year>2016</year><volume>56</volume><issue>9</issue><fpage>1553</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1111/head.12952</pub-id><?supplied-pmid 27699772?><pub-id pub-id-type="pmid">27699772</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finocchi</surname><given-names>C</given-names></name><name><surname>Sivori</surname><given-names>G</given-names></name></person-group><article-title>Food as trigger and aggravating factor of migraine</article-title><source>Neurol Sci</source><year>2012</year><volume>33</volume><issue>Suppl 1</issue><fpage>S77</fpage><lpage>S80</lpage><pub-id pub-id-type="doi">10.1007/s10072-012-1046-5</pub-id><?supplied-pmid 22644176?><pub-id pub-id-type="pmid">22644176</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Sirianni</surname><given-names>G</given-names></name><name><surname>Pierelli</surname><given-names>F</given-names></name></person-group><article-title>Short term improvement of migraine headaches during ketogenic diet: a prospective observational study in a dietician clinical setting</article-title><source>J Headache Pain</source><year>2013</year><volume>14</volume><issue>1</issue><fpage>P219</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-14-S1-P219</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bara&#x000f1;ano</surname><given-names>KW</given-names></name><name><surname>Hartman</surname><given-names>AL</given-names></name></person-group><article-title>The ketogenic diet: uses in epilepsy and other neurologic illnesses</article-title><source>Curr Treat Options Neurol</source><year>2008</year><volume>10</volume><issue>6</issue><fpage>410</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1007/s11940-008-0043-8</pub-id><?supplied-pmid 18990309?><pub-id pub-id-type="pmid">18990309</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mahan</surname><given-names>LK</given-names></name><name><surname>Raymond</surname><given-names>JL</given-names></name></person-group><source>Krause's food &#x00026; the nutrition care process-e-book: Elsevier health sciences</source><year>2016</year></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>J</given-names></name><name><surname>Bowen</surname><given-names>EJ</given-names></name><name><surname>Russo</surname><given-names>AF</given-names></name><name><surname>Durham</surname><given-names>PL</given-names></name></person-group><article-title>Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons</article-title><source>Eur J Neurosci</source><year>2006</year><volume>23</volume><issue>8</issue><fpage>2057</fpage><lpage>2066</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04742.x</pub-id><?supplied-pmid 16630053?><pub-id pub-id-type="pmid">16630053</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alpay</surname><given-names>K</given-names></name><name><surname>Erta&#x0015f;</surname><given-names>M</given-names></name><name><surname>Orhan</surname><given-names>EK</given-names></name><name><surname>&#x000dc;stay</surname><given-names>DK</given-names></name><name><surname>Lieners</surname><given-names>C</given-names></name><name><surname>Baykan</surname><given-names>B</given-names></name></person-group><article-title>Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial</article-title><source>Cephalalgia</source><year>2010</year><volume>30</volume><issue>7</issue><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1177/0333102410361404</pub-id><?supplied-pmid 20647174?><pub-id pub-id-type="pmid">20647174</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le May</surname><given-names>C</given-names></name><name><surname>Pineau</surname><given-names>T</given-names></name><name><surname>Bigot</surname><given-names>K</given-names></name><name><surname>Kohl</surname><given-names>C</given-names></name><name><surname>Girard</surname><given-names>J</given-names></name><name><surname>P&#x000e9;gorier</surname><given-names>J-P</given-names></name></person-group><article-title>Reduced hepatic fatty acid oxidation in fasting PPAR&#x003b1; null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression</article-title><source>FEBS Lett</source><year>2000</year><volume>475</volume><issue>3</issue><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01648-3</pub-id><?supplied-pmid 10869548?><pub-id pub-id-type="pmid">10869548</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>R</given-names></name><name><surname>Faizy</surname><given-names>AF</given-names></name><name><surname>Siddiqui</surname><given-names>SS</given-names></name><name><surname>Singhai</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of TNF-&#x003b1; and IL-6 levels in obese and non-obese diabetics: pre- and Postinsulin effects</article-title><source>N Am J Med Sci</source><year>2012</year><volume>4</volume><issue>4</issue><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.4103/1947-2714.94944</pub-id><?supplied-pmid 22536561?><pub-id pub-id-type="pmid">22536561</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popko</surname><given-names>K</given-names></name><name><surname>Gorska</surname><given-names>E</given-names></name><name><surname>Stelmaszczyk-Emmel</surname><given-names>A</given-names></name><name><surname>Plywaczewski</surname><given-names>R</given-names></name><name><surname>Stoklosa</surname><given-names>A</given-names></name><name><surname>Gorecka</surname><given-names>D</given-names></name><etal/></person-group><article-title>Proinflammatory cytokines Il-6 and TNF-&#x003b1; and the development of inflammation in obese subjects</article-title><source>Euro J Med Res</source><year>2010</year><volume>15</volume><issue>Suppl 2</issue><fpage>120</fpage><lpage>122</lpage></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forny-Germano</surname><given-names>L</given-names></name><name><surname>De Felice</surname><given-names>FG</given-names></name><name><surname>MNdN</surname><given-names>V</given-names></name></person-group><article-title>The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer&#x02019;s Disease</article-title><source>Front Neurosci</source><year>2019</year><volume>12</volume><fpage>1027</fpage><pub-id pub-id-type="doi">10.3389/fnins.2018.01027</pub-id><?supplied-pmid 30692905?><pub-id pub-id-type="pmid">30692905</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterlin</surname><given-names>BL</given-names></name><name><surname>Sacco</surname><given-names>S</given-names></name><name><surname>Bernecker</surname><given-names>C</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name></person-group><article-title>Adipokines and migraine: a systematic review</article-title><source>Headache.</source><year>2016</year><volume>56</volume><issue>4</issue><fpage>622</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1111/head.12788</pub-id><?supplied-pmid 27012149?><pub-id pub-id-type="pmid">27012149</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterlin</surname><given-names>BL</given-names></name></person-group><article-title>The role of the Adipocytokines Adiponectin and Leptin in migraine</article-title><source>J Am Osteopathic Assoc</source><year>2009</year><volume>109</volume><issue>6</issue><fpage>314</fpage><lpage>317</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>JE</given-names></name><name><surname>Halford</surname><given-names>JC</given-names></name></person-group><article-title>Serotonin and appetite regulation</article-title><source>CNS Drugs</source><year>1998</year><volume>9</volume><issue>6</issue><fpage>473</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.2165/00023210-199809060-00005</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deen</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>CE</given-names></name><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>HD</given-names></name><name><surname>Knudsen</surname><given-names>GM</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name></person-group><article-title>Serotonergic mechanisms in the migraine brain&#x02013;a systematic review</article-title><source>Cephalalgia.</source><year>2017</year><volume>37</volume><issue>3</issue><fpage>251</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1177/0333102416640501</pub-id><?supplied-pmid 27013238?><pub-id pub-id-type="pmid">27013238</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasparini</surname><given-names>CF</given-names></name><name><surname>Smith</surname><given-names>RA</given-names></name><name><surname>Griffiths</surname><given-names>LR</given-names></name></person-group><article-title>Genetic and biochemical changes of the serotonergic system in migraine pathobiology</article-title><source>J Headache Pain</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0711-0</pub-id><?supplied-pmid 28194570?><pub-id pub-id-type="pmid">28194570</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>R</given-names></name></person-group><article-title>Neurogenic inflammation and its role in migraine</article-title><source>Semin Immunopathol</source><year>2018</year><volume>40</volume><issue>3</issue><fpage>301</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1007/s00281-018-0676-y</pub-id><?supplied-pmid 29568973?><pub-id pub-id-type="pmid">29568973</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Haanes</surname><given-names>KA</given-names></name><name><surname>Warfvinge</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>DN</given-names></name></person-group><article-title>CGRP as the target of new migraine therapies&#x02014;successful translation from bench to clinic</article-title><source>Nat Rev Neurol</source><year>2018</year><volume>14</volume><issue>6</issue><fpage>338</fpage><pub-id pub-id-type="doi">10.1038/s41582-018-0003-1</pub-id><?supplied-pmid 29691490?><pub-id pub-id-type="pmid">29691490</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Edvinsson L (2019) Role of CGRP in migraine. Handb Exp Pharmacol 255:121&#x02013;30.</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarty</surname><given-names>MF</given-names></name></person-group><article-title>The origins of western obesity: a role for animal protein?</article-title><source>Med Hypotheses</source><year>2000</year><volume>54</volume><issue>3</issue><fpage>488</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1054/mehy.1999.0882</pub-id><?supplied-pmid 10783494?><pub-id pub-id-type="pmid">10783494</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Rapoport</surname><given-names>AM</given-names></name></person-group><article-title>Obesity and chronic daily headache</article-title><source>Curr Pain Headache Rep</source><year>2012</year><volume>16</volume><issue>1</issue><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s11916-011-0232-0</pub-id><?supplied-pmid 22076673?><pub-id pub-id-type="pmid">22076673</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manfield</surname><given-names>JH</given-names></name><name><surname>Yu</surname><given-names>KK</given-names></name><name><surname>Efthimiou</surname><given-names>E</given-names></name><name><surname>Darzi</surname><given-names>A</given-names></name><name><surname>Athanasiou</surname><given-names>T</given-names></name><name><surname>Ashrafian</surname><given-names>H</given-names></name></person-group><article-title>Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses</article-title><source>Obes Surg</source><year>2017</year><volume>27</volume><issue>2</issue><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1007/s11695-016-2467-7</pub-id><?supplied-pmid 27981458?><pub-id pub-id-type="pmid">27981458</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahromi</surname><given-names>SR</given-names></name><name><surname>Abolhassani</surname><given-names>M</given-names></name><name><surname>Meysamie</surname><given-names>A</given-names></name><name><surname>Togha</surname><given-names>M</given-names></name></person-group><article-title>The effect body fat mass and fat free mass on migraine headache</article-title><source>Iran J Neurol</source><year>2013</year><volume>12</volume><issue>1</issue><fpage>23</fpage><lpage>27</lpage><?supplied-pmid 24250893?><pub-id pub-id-type="pmid">24250893</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gano</surname><given-names>L</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Rho</surname><given-names>JM</given-names></name></person-group><article-title>Ketogenic diets, mitochondria and neurological diseases</article-title><source>J Lipid Res</source><year>2014</year><volume>55</volume><issue>11</issue><fpage>2211</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1194/jlr.R048975</pub-id><?supplied-pmid 24847102?><pub-id pub-id-type="pmid">24847102</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maalouf</surname><given-names>M</given-names></name><name><surname>Rho</surname><given-names>JM</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><article-title>The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies</article-title><source>Brain Res Rev</source><year>2009</year><volume>59</volume><issue>2</issue><fpage>293</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.09.002</pub-id><?supplied-pmid 18845187?><pub-id pub-id-type="pmid">18845187</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rho</surname><given-names>JM</given-names></name><name><surname>Stafstrom</surname><given-names>CE</given-names></name></person-group><article-title>The ketogenic diet as a treatment paradigm for diverse neurological disorders</article-title><source>Front Pharmacol</source><year>2012</year><volume>3</volume><fpage>59</fpage><?supplied-pmid 22509165?><pub-id pub-id-type="pmid">22509165</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahlman</surname><given-names>RS</given-names></name></person-group><article-title>Can ketosis help migraine sufferers? A case report</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>1</issue><fpage>182</fpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00321_5.x</pub-id><?supplied-pmid 16412174?><pub-id pub-id-type="pmid">16412174</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BARBORKA</surname><given-names>CJ</given-names></name></person-group><article-title>Migraine: results of treatment by ketogenic diet in fifty cases</article-title><source>J Am Med Assoc</source><year>1930</year><volume>95</volume><issue>24</issue><fpage>1825</fpage><lpage>1828</lpage><pub-id pub-id-type="doi">10.1001/jama.1930.02720240035010</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Bracaglia</surname><given-names>M</given-names></name><name><surname>Di Lenola</surname><given-names>D</given-names></name><name><surname>Evangelista</surname><given-names>M</given-names></name><name><surname>Sirianni</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study</article-title><source>J Headache Pain</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0650-9</pub-id><?supplied-pmid 27245682?><pub-id pub-id-type="pmid">27245682</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Sirianni</surname><given-names>G</given-names></name><name><surname>Di Lorenzo</surname><given-names>G</given-names></name><name><surname>Bracaglia</surname><given-names>M</given-names></name><name><surname>Di Lenola</surname><given-names>D</given-names></name><etal/></person-group><article-title>Migraine improvement during short lasting ketogenesis: a proof-of-concept study</article-title><source>Eur J Neurol</source><year>2015</year><volume>22</volume><issue>1</issue><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1111/ene.12550</pub-id><?supplied-pmid 25156013?><pub-id pub-id-type="pmid">25156013</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kossoff</surname><given-names>E</given-names></name><name><surname>Huffman</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>Z</given-names></name><name><surname>Gladstein</surname><given-names>J</given-names></name></person-group><article-title>Use of the modified Atkins diet for adolescents with chronic daily headache</article-title><source>Cephalalgia</source><year>2010</year><volume>30</volume><issue>8</issue><fpage>1014</fpage><lpage>1016</lpage><?supplied-pmid 20656714?><pub-id pub-id-type="pmid">20656714</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Shan</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group><article-title>Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><fpage>585</fpage><pub-id pub-id-type="doi">10.3389/fneur.2019.00585</pub-id><?supplied-pmid 31244753?><pub-id pub-id-type="pmid">31244753</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SCHNABEL</surname><given-names>TG</given-names></name></person-group><article-title>An experience with a Ketogenic dietary in migraine*</article-title><source>Ann Intern Med</source><year>1928</year><volume>2</volume><issue>4</issue><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-2-4-341</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Curr&#x000e0;</surname><given-names>A</given-names></name><name><surname>Sirianni</surname><given-names>G</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Bracaglia</surname><given-names>M</given-names></name><name><surname>Cardillo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Diet transiently improves migraine in two twin sisters: possible role of ketogenesis?</article-title><source>Funct Neurol</source><year>2013</year><volume>28</volume><issue>4</issue><fpage>305</fpage><?supplied-pmid 24598400?><pub-id pub-id-type="pmid">24598400</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbizu</surname><given-names>A</given-names></name><name><surname>Cuenca-Le&#x000f3;n</surname><given-names>E</given-names></name><name><surname>Raspall-Chaure</surname><given-names>M</given-names></name><name><surname>Gratac&#x000f2;s</surname><given-names>M</given-names></name><name><surname>Conill</surname><given-names>J</given-names></name><name><surname>Redecillas</surname><given-names>S</given-names></name><etal/></person-group><article-title>Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation</article-title><source>J Neurol Sci</source><year>2010</year><volume>295</volume><issue>1&#x02013;2</issue><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2010.05.017</pub-id><?supplied-pmid 20621801?><pub-id pub-id-type="pmid">20621801</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Wirrell E (2012) In: Elizabeth N (ed) Dietary treatment of epilepsy. Practical implementation of ketogenic therapy. Wiley-Blackwell 241 pages. C $80 approx. Canadian journal of neurological sciences. 2013;40(3):440</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhamija</surname><given-names>R</given-names></name><name><surname>Eckert</surname><given-names>S</given-names></name><name><surname>Wirrell</surname><given-names>E</given-names></name></person-group><article-title>Ketogenic diet</article-title><source>Can J Neurol Sci</source><year>2013</year><volume>40</volume><issue>2</issue><fpage>158</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1017/S0317167100013676</pub-id><?supplied-pmid 23419562?><pub-id pub-id-type="pmid">23419562</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evcili</surname><given-names>G</given-names></name><name><surname>Utku</surname><given-names>U</given-names></name><name><surname>&#x000d6;&#x0011f;&#x000fc;n</surname><given-names>MN</given-names></name><name><surname>&#x000d6;zdemir</surname><given-names>G</given-names></name></person-group><article-title>Early and long period follow-up results of low glycemic index diet for migraine prophylaxis</article-title><source>Agr&#x00131;</source><year>2018</year><volume>30</volume><issue>1</issue><fpage>8</fpage><lpage>11</lpage><?supplied-pmid 29450870?><pub-id pub-id-type="pmid">29450870</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>H-C</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HD</given-names></name></person-group><article-title>Low glycemic index treatment in patients with drug-resistant epilepsy</article-title><source>Brain Dev</source><year>2017</year><volume>39</volume><issue>8</issue><fpage>687</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.braindev.2017.03.027</pub-id><?supplied-pmid 28431772?><pub-id pub-id-type="pmid">28431772</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>TJ</given-names></name><name><surname>Albert</surname><given-names>PS</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Bagshaw</surname><given-names>D</given-names></name><name><surname>Kris-Etherton</surname><given-names>PM</given-names></name><name><surname>Ulbrecht</surname><given-names>J</given-names></name><etal/></person-group><article-title>Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal Cancer1</article-title><source>J Nutr</source><year>2009</year><volume>140</volume><issue>1</issue><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.3945/jn.109.114249</pub-id><?supplied-pmid 19889807?><pub-id pub-id-type="pmid">19889807</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVivo</surname><given-names>DC</given-names></name><name><surname>Leckie</surname><given-names>MP</given-names></name><name><surname>Ferrendelli</surname><given-names>JS</given-names></name><name><surname>McDougal</surname><given-names>DB</given-names><suffix>Jr</suffix></name></person-group><article-title>Chronic ketosis and cerebral metabolism</article-title><source>Ann Neurol</source><year>1978</year><volume>3</volume><issue>4</issue><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1002/ana.410030410</pub-id><?supplied-pmid 666275?><pub-id pub-id-type="pmid">666275</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Almeida Rabello Oliveira</surname><given-names>M</given-names></name><name><surname>da Rocha</surname><given-names>AT</given-names></name><name><surname>de Oliveira</surname><given-names>SL</given-names></name><name><surname>de Melo Lucena</surname><given-names>AL</given-names></name><name><surname>de Lira</surname><given-names>CE</given-names></name><name><surname>Soares</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats</article-title><source>Neurosci Lett</source><year>2008</year><volume>434</volume><issue>1</issue><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2008.01.032</pub-id><?supplied-pmid 18281154?><pub-id pub-id-type="pmid">18281154</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>EA</given-names></name><name><surname>Jeon</surname><given-names>BT</given-names></name><name><surname>Shin</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Ketogenic diet-induced peroxisome proliferator-activated receptor-&#x003b3; activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures</article-title><source>Exp Neurol</source><year>2011</year><volume>232</volume><issue>2</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2011.09.001</pub-id><?supplied-pmid 21939657?><pub-id pub-id-type="pmid">21939657</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amitani</surname><given-names>M</given-names></name><name><surname>Amitani</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>K-C</given-names></name><name><surname>Kairupan</surname><given-names>TS</given-names></name><name><surname>Sameshima</surname><given-names>N</given-names></name><name><surname>Shimoshikiryo</surname><given-names>I</given-names></name><etal/></person-group><article-title>The role of ghrelin and ghrelin signaling in aging</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>7</issue><fpage>1511</fpage><pub-id pub-id-type="doi">10.3390/ijms18071511</pub-id><?supplied-pmid 5536001?><pub-id pub-id-type="pmid">5536001</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scher</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>W</given-names></name><name><surname>Ricci</surname><given-names>J</given-names></name><name><surname>Lipton</surname><given-names>R</given-names></name></person-group><article-title>Factors associated with the onset and remission of chronic daily headache in a population-based study</article-title><source>Pain</source><year>2003</year><volume>106</volume><issue>1&#x02013;2</issue><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00293-8</pub-id><?supplied-pmid 14581114?><pub-id pub-id-type="pmid">14581114</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>D</given-names></name><name><surname>Vithiananthan</surname><given-names>S</given-names></name><name><surname>Nash</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Wing</surname><given-names>R</given-names></name></person-group><article-title>Improvement of migraine headaches in severely obese patients after bariatric surgery</article-title><source>Neurology</source><year>2011</year><volume>76</volume><issue>13</issue><fpage>1135</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318212ab1e</pub-id><?supplied-pmid 21444898?><pub-id pub-id-type="pmid">21444898</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahromi</surname><given-names>SR</given-names></name><name><surname>Abolhasani</surname><given-names>M</given-names></name><name><surname>Ghorbani</surname><given-names>Z</given-names></name><name><surname>Sadre-Jahani</surname><given-names>S</given-names></name><name><surname>Alizadeh</surname><given-names>Z</given-names></name><name><surname>Talebpour</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache</article-title><source>Obes Surg</source><year>2018</year><volume>28</volume><issue>1</issue><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/s11695-017-2793-4</pub-id><pub-id pub-id-type="pmid">28685361</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novack</surname><given-names>V</given-names></name><name><surname>Fuchs</surname><given-names>L</given-names></name><name><surname>Lantsberg</surname><given-names>L</given-names></name><name><surname>Kama</surname><given-names>S</given-names></name><name><surname>Lahoud</surname><given-names>U</given-names></name><name><surname>Horev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series</article-title><source>Cephalalgia</source><year>2011</year><volume>31</volume><issue>13</issue><fpage>1336</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1177/0333102411413162</pub-id><?supplied-pmid 21700645?><pub-id pub-id-type="pmid">21700645</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachdev</surname><given-names>A</given-names></name><name><surname>Marmura</surname><given-names>MJ</given-names></name></person-group><article-title>Metabolic syndrome and migraine</article-title><source>Front Neurol</source><year>2012</year><volume>3</volume><fpage>161</fpage><pub-id pub-id-type="doi">10.3389/fneur.2012.00161</pub-id><?supplied-pmid 23181051?><pub-id pub-id-type="pmid">23181051</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavestro</surname><given-names>C</given-names></name><name><surname>Rosatello</surname><given-names>A</given-names></name><name><surname>Micca</surname><given-names>G</given-names></name><name><surname>Ravotto</surname><given-names>M</given-names></name><name><surname>Pia Marino</surname><given-names>M</given-names></name><name><surname>Asteggiano</surname><given-names>G</given-names></name><etal/></person-group><article-title>Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine?</article-title><source>Headache</source><year>2007</year><volume>47</volume><issue>10</issue><fpage>1436</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2007.00719.x</pub-id><?supplied-pmid 18052953?><pub-id pub-id-type="pmid">18052953</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhoi</surname><given-names>SK</given-names></name><name><surname>Kalita</surname><given-names>J</given-names></name><name><surname>Misra</surname><given-names>UK</given-names></name></person-group><article-title>Metabolic syndrome and insulin resistance in migraine</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><issue>4</issue><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1007/s10194-012-0416-y</pub-id><?supplied-pmid 22278639?><pub-id pub-id-type="pmid">22278639</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laino</surname><given-names>D</given-names></name><name><surname>Vitaliti</surname><given-names>G</given-names></name><name><surname>Parisi</surname><given-names>P</given-names></name><name><surname>Pavone</surname><given-names>P</given-names></name><name><surname>Verrotti</surname><given-names>A</given-names></name><name><surname>Lubrano</surname><given-names>R</given-names></name><etal/></person-group><article-title>Headache, migraine and obesity: an overview on plausible links</article-title><source>J Biol Regul Homeost Agents</source><year>2016</year><volume>30</volume><issue>2</issue><fpage>333</fpage><lpage>338</lpage><?supplied-pmid 27358118?><pub-id pub-id-type="pmid">27358118</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietjen</surname><given-names>GE</given-names></name><name><surname>Khubchandani</surname><given-names>J</given-names></name></person-group><article-title>Vascular biomarkers in migraine</article-title><source>Cephalalgia.</source><year>2015</year><volume>35</volume><issue>2</issue><fpage>95</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1177/0333102414544976</pub-id><?supplied-pmid 25281220?><pub-id pub-id-type="pmid">25281220</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarchielli</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>A</given-names></name><name><surname>Baldi</surname><given-names>A</given-names></name><name><surname>Coppola</surname><given-names>F</given-names></name><name><surname>Rossi</surname><given-names>C</given-names></name><name><surname>Pierguidi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>2</issue><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00337.x</pub-id><?supplied-pmid 16492228?><pub-id pub-id-type="pmid">16492228</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidan</surname><given-names>I</given-names></name><name><surname>Yuksel</surname><given-names>S</given-names></name><name><surname>Ymir</surname><given-names>T</given-names></name><name><surname>Irkec</surname><given-names>C</given-names></name><name><surname>Aksakal</surname><given-names>FN</given-names></name></person-group><article-title>The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine</article-title><source>J Neuroimmunol</source><year>2006</year><volume>171</volume><issue>1&#x02013;2</issue><fpage>184</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2005.10.005</pub-id><?supplied-pmid 16325275?><pub-id pub-id-type="pmid">16325275</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="other">Tietjen G, Khubchandani J, Khan A, Herial N. (2010) Adiponectin and Inflammatory Cytokines in Young Women with Migraine&#x000a0;Program Late&#x02010;Breaking Abstracts. Headache: 50:S71&#x02013;S79.</mixed-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Y&#x000fc;cel</surname><given-names>M</given-names></name><name><surname>Kotan</surname><given-names>D</given-names></name><name><surname>&#x000c7;ift&#x000e7;i</surname><given-names>GG</given-names></name><name><surname>&#x000c7;ift&#x000e7;i</surname><given-names>I</given-names></name><name><surname>Cikriklar</surname><given-names>H</given-names></name></person-group><article-title>Serum levels of endocan, claudin-5 and cytokines in migraine</article-title><source>Eur Rev Med Pharmacol Sci</source><year>2016</year><volume>20</volume><issue>5</issue><fpage>930</fpage><lpage>936</lpage><?supplied-pmid 27010153?><pub-id pub-id-type="pmid">27010153</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martami</surname><given-names>F</given-names></name><name><surname>Razeghi Jahromi</surname><given-names>S</given-names></name><name><surname>Togha</surname><given-names>M</given-names></name><name><surname>Ghorbani</surname><given-names>Z</given-names></name><name><surname>Seifishahpar</surname><given-names>M</given-names></name><name><surname>Saidpour</surname><given-names>A</given-names></name></person-group><article-title>The serum level of inflammatory markers in chronic and episodic migraine: a case-control study</article-title><source>Neurol Sci</source><year>2018</year><volume>39</volume><issue>10</issue><fpage>1741</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1007/s10072-018-3493-0</pub-id><?supplied-pmid 30009333?><pub-id pub-id-type="pmid">30009333</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>DS</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Nash</surname><given-names>JM</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name></person-group><article-title>Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment</article-title><source>Obes Rev</source><year>2011</year><volume>12</volume><issue>5</issue><fpage>e362</fpage><lpage>ee71</lpage><pub-id pub-id-type="doi">10.1111/j.1467-789X.2010.00791.x</pub-id><?supplied-pmid 20673279?><pub-id pub-id-type="pmid">20673279</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zelissen</surname><given-names>PM</given-names></name><name><surname>Koppeschaar</surname><given-names>HP</given-names></name><name><surname>Lips</surname><given-names>CJ</given-names></name><name><surname>Hackeng</surname><given-names>WH</given-names></name></person-group><article-title>Calcitonin gene-related peptide in human obesity</article-title><source>Peptides</source><year>1991</year><volume>12</volume><issue>4</issue><fpage>861</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1016/0196-9781(91)90147-H</pub-id><?supplied-pmid 1788147?><pub-id pub-id-type="pmid">1788147</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>CS</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Whiting</surname><given-names>L</given-names></name><name><surname>Glyn-Jones</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Hickey</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity</article-title><source>Endocrinology.</source><year>2010</year><volume>151</volume><issue>9</issue><fpage>4257</fpage><lpage>4269</lpage><pub-id pub-id-type="doi">10.1210/en.2010-0284</pub-id><?supplied-pmid 20610563?><pub-id pub-id-type="pmid">20610563</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gram</surname><given-names>DX</given-names></name><name><surname>Hansen</surname><given-names>AJ</given-names></name><name><surname>Wilken</surname><given-names>M</given-names></name><name><surname>Elm</surname><given-names>T</given-names></name><name><surname>Svendsen</surname><given-names>O</given-names></name><name><surname>Carr</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats</article-title><source>Eur J Endocrinol</source><year>2005</year><volume>153</volume><issue>6</issue><fpage>963</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1530/eje.1.02046</pub-id><?supplied-pmid 16322403?><pub-id pub-id-type="pmid">16322403</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Obesity, migraine, and chronic migraine possible mechanisms of interaction</article-title><source>Neurology.</source><year>2007</year><volume>68</volume><issue>21</issue><fpage>1851</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000262045.11646.b1</pub-id><?supplied-pmid 17515549?><pub-id pub-id-type="pmid">17515549</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achari</surname><given-names>AE</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name></person-group><article-title>Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>6</issue><fpage>1321</fpage><pub-id pub-id-type="doi">10.3390/ijms18061321</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutlu</surname><given-names>S</given-names></name><name><surname>Canpolat</surname><given-names>S</given-names></name><name><surname>Sandal</surname><given-names>S</given-names></name><name><surname>Ozcan</surname><given-names>M</given-names></name><name><surname>Sarsilmaz</surname><given-names>M</given-names></name><name><surname>Kelestimur</surname><given-names>H</given-names></name></person-group><article-title>Effects of central and peripheral administration of leptin on pain threshold in rats and mice</article-title><source>Neuro Endocrinol Lett</source><year>2003</year><volume>24</volume><issue>3&#x02013;4</issue><fpage>193</fpage><lpage>196</lpage><?supplied-pmid 14523356?><pub-id pub-id-type="pmid">14523356</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strother</surname><given-names>LC</given-names></name><name><surname>Srikiatkhachorn</surname><given-names>A</given-names></name><name><surname>Supronsinchai</surname><given-names>W</given-names></name></person-group><article-title>Targeted Orexin and hypothalamic neuropeptides for migraine</article-title><source>Neurotherapeutics</source><year>2018</year><volume>15</volume><issue>2</issue><fpage>377</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1007/s13311-017-0602-3</pub-id><?supplied-pmid 29442286?><pub-id pub-id-type="pmid">29442286</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bic</surname><given-names>Z</given-names></name><name><surname>Blix</surname><given-names>GG</given-names></name><name><surname>Hopp</surname><given-names>HP</given-names></name><name><surname>Leslie</surname><given-names>FM</given-names></name><name><surname>Schell</surname><given-names>MJ</given-names></name></person-group><article-title>The influence of a low-fat diet on incidence and severity of migraine headaches</article-title><source>J Women&#x02019;s Health Gender-Based Med</source><year>1999</year><volume>8</volume><issue>5</issue><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1089/jwh.1.1999.8.623</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunner</surname><given-names>AE</given-names></name><name><surname>Agarwal</surname><given-names>U</given-names></name><name><surname>Gonzales</surname><given-names>JF</given-names></name><name><surname>Valente</surname><given-names>F</given-names></name><name><surname>Barnard</surname><given-names>ND</given-names></name></person-group><article-title>Nutrition intervention for migraine: a randomized crossover trial</article-title><source>J Headache Pain</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-15-69</pub-id><?supplied-pmid 25339342?><pub-id pub-id-type="pmid">25339342</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>L</given-names></name><name><surname>Pacioni</surname><given-names>D</given-names></name><name><surname>Di Fronzo</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>B</given-names></name><name><surname>Speranza</surname><given-names>E</given-names></name><name><surname>Carlino</surname><given-names>V</given-names></name><etal/></person-group><article-title>Low-lipid diet reduces frequency and severity of acute migraine attacks</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2015</year><volume>25</volume><issue>4</issue><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2014.12.006</pub-id><?supplied-pmid 25698152?><pub-id pub-id-type="pmid">25698152</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsden</surname><given-names>CE</given-names></name><name><surname>Zamora</surname><given-names>D</given-names></name><name><surname>Makriyannis</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>JT</given-names></name><name><surname>Mann</surname><given-names>JD</given-names></name><name><surname>Faurot</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Diet-induced changes in n-3-and n-6-derived endocannabinoids and reductions in headache pain and psychological distress</article-title><source>J Pain</source><year>2015</year><volume>16</volume><issue>8</issue><fpage>707</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2015.04.007</pub-id><?supplied-pmid 25958314?><pub-id pub-id-type="pmid">25958314</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdolahi</surname><given-names>M</given-names></name><name><surname>Tafakhori</surname><given-names>A</given-names></name><name><surname>Togha</surname><given-names>M</given-names></name><name><surname>Okhovat</surname><given-names>AA</given-names></name><name><surname>Siassi</surname><given-names>F</given-names></name><name><surname>Eshraghian</surname><given-names>MR</given-names></name><etal/></person-group><article-title>The synergistic effects of &#x003c9;-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-&#x003b1; gene expression and serum level in migraine patients</article-title><source>Immunogenetics.</source><year>2017</year><volume>69</volume><issue>6</issue><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1007/s00251-017-0992-8</pub-id><?supplied-pmid 28478481?><pub-id pub-id-type="pmid">28478481</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horrobin</surname><given-names>D</given-names></name></person-group><article-title>Prostaglandins and migraine</article-title><source>Headache</source><year>1977</year><volume>17</volume><issue>3</issue><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.1977.hed1703113.x</pub-id><?supplied-pmid 330466?><pub-id pub-id-type="pmid">330466</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>BJ</given-names></name><name><surname>Morel-Kopp</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Tofler</surname><given-names>GH</given-names></name><name><surname>Ward</surname><given-names>CM</given-names></name></person-group><article-title>Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease</article-title><source>Semin Thromb Hemost</source><year>2013</year><volume>39</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1333309</pub-id><?supplied-pmid 23329646?><pub-id pub-id-type="pmid">23329646</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrick</surname><given-names>RP</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name></person-group><article-title>Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior</article-title><source>FASEB J</source><year>2015</year><volume>29</volume><issue>6</issue><fpage>2207</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.1096/fj.14-268342</pub-id><?supplied-pmid 25713056?><pub-id pub-id-type="pmid">25713056</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>AC</given-names></name><name><surname>Colman</surname><given-names>RW</given-names></name><name><surname>Lees</surname><given-names>RS</given-names></name></person-group><article-title>Platelet function in hyperlipoproteinemia</article-title><source>N Engl J Med</source><year>1974</year><volume>290</volume><issue>8</issue><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1056/NEJM197402212900805</pub-id><?supplied-pmid 4359434?><pub-id pub-id-type="pmid">4359434</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zbinden</surname><given-names>G</given-names></name></person-group><article-title>Transient thrombopenia after intravenous injection of certain fatty acids</article-title><source>J Lipid Res</source><year>1964</year><volume>5</volume><issue>3</issue><fpage>378</fpage><lpage>384</lpage><?supplied-pmid 5873376?><pub-id pub-id-type="pmid">5873376</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgdorff</surname><given-names>P</given-names></name><name><surname>Tangelder</surname><given-names>GJ</given-names></name></person-group><article-title>Migraine: possible role of shear-induced platelet aggregation with serotonin release</article-title><source>Headache</source><year>2012</year><volume>52</volume><issue>8</issue><fpage>1298</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02162.x</pub-id><?supplied-pmid 22568554?><pub-id pub-id-type="pmid">22568554</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>PT</given-names></name><name><surname>Goncalves</surname><given-names>TR</given-names></name><name><surname>Strabelli</surname><given-names>CG</given-names></name><name><surname>Lucchino</surname><given-names>NM</given-names></name><name><surname>Matos</surname><given-names>FC</given-names></name><name><surname>Santos</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Trigger factors in migraine patients</article-title><source>Arq Neuropsiquiatr</source><year>2008</year><volume>66</volume><issue>3a</issue><fpage>494</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1590/S0004-282X2008000400011</pub-id><?supplied-pmid 18813707?><pub-id pub-id-type="pmid">18813707</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peatfield</surname><given-names>RC</given-names></name><name><surname>Glover</surname><given-names>V</given-names></name><name><surname>Littlewood</surname><given-names>JT</given-names></name><name><surname>Sandler</surname><given-names>M</given-names></name><name><surname>Clifford</surname><given-names>RF</given-names></name></person-group><article-title>The prevalence of diet-induced migraine</article-title><source>Cephalalgia</source><year>1984</year><volume>4</volume><issue>3</issue><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1984.0403179.x</pub-id><?supplied-pmid 6498931?><pub-id pub-id-type="pmid">6498931</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcus</surname><given-names>DA</given-names></name><name><surname>Scharff</surname><given-names>L</given-names></name><name><surname>Turk</surname><given-names>D</given-names></name><name><surname>Gourley</surname><given-names>LM</given-names></name></person-group><article-title>A double-blind provocative study chocolate as a trigger of headache</article-title><source>Cephalalgia</source><year>1997</year><volume>17</volume><issue>8</issue><fpage>855</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1997.1708855.x</pub-id><?supplied-pmid 9453274?><pub-id pub-id-type="pmid">9453274</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydinlar</surname><given-names>EI</given-names></name><name><surname>Dikmen</surname><given-names>PY</given-names></name><name><surname>Tiftikci</surname><given-names>A</given-names></name><name><surname>Saruc</surname><given-names>M</given-names></name><name><surname>Aksu</surname><given-names>M</given-names></name><name><surname>Gunsoy</surname><given-names>HG</given-names></name><etal/></person-group><article-title>IgG-based elimination diet in migraine plus irritable bowel syndrome</article-title><source>Headache</source><year>2013</year><volume>53</volume><issue>3</issue><fpage>514</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02296.x</pub-id><?supplied-pmid 23216231?><pub-id pub-id-type="pmid">23216231</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>N</given-names></name><name><surname>Hewitt</surname><given-names>CE</given-names></name><name><surname>Jayakody</surname><given-names>S</given-names></name><name><surname>Islam</surname><given-names>M</given-names></name><name><surname>Adamson</surname><given-names>J</given-names></name><name><surname>Watt</surname><given-names>I</given-names></name><etal/></person-group><article-title>Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches</article-title><source>Nutr J</source><year>2011</year><volume>10</volume><issue>1</issue><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-10-85</pub-id><?supplied-pmid 21835022?><pub-id pub-id-type="pmid">21835022</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>SL</given-names></name></person-group><article-title>Diet and nutraceutical interventions for headache management: a review of the evidence</article-title><source>Cephalalgia</source><year>2016</year><volume>36</volume><issue>12</issue><fpage>1112</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1177/0333102415590239</pub-id><?supplied-pmid 26069242?><pub-id pub-id-type="pmid">26069242</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wantke</surname><given-names>F</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>M</given-names></name><name><surname>Jarisch</surname><given-names>R</given-names></name></person-group><article-title>Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronical headaches</article-title><source>Clin Exp Allergy</source><year>1993</year><volume>23</volume><issue>12</issue><fpage>982</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.1993.tb00287.x</pub-id><?supplied-pmid 10779289?><pub-id pub-id-type="pmid">10779289</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehle</surname><given-names>ME</given-names></name></person-group><article-title>Migraine and allergy: a review and clinical update</article-title><source>Curr Allergy Asthma Rep</source><year>2012</year><volume>12</volume><issue>3</issue><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1007/s11882-012-0251-x</pub-id><?supplied-pmid 22359068?><pub-id pub-id-type="pmid">22359068</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>VT</given-names></name><name><surname>Taylor</surname><given-names>F</given-names></name><name><surname>Gebhardt</surname><given-names>B</given-names></name><name><surname>Tomaszewski</surname><given-names>M</given-names></name><name><surname>Ellison</surname><given-names>JS</given-names></name><name><surname>Martin</surname><given-names>GV</given-names></name><etal/></person-group><article-title>Allergy and immunotherapy: are they related to migraine headache?</article-title><source>Headache</source><year>2011</year><volume>51</volume><issue>1</issue><fpage>8</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2010.01792.x</pub-id><?supplied-pmid 21054364?><pub-id pub-id-type="pmid">21054364</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lackner</surname><given-names>S</given-names></name><name><surname>Malcher</surname><given-names>V</given-names></name><name><surname>Enko</surname><given-names>D</given-names></name><name><surname>Mangge</surname><given-names>H</given-names></name><name><surname>Holasek</surname><given-names>SJ</given-names></name><name><surname>Schnedl</surname><given-names>WJ</given-names></name></person-group><article-title>Histamine-reduced diet and increase of serum diamine oxidase correlating to diet compliance in histamine intolerance</article-title><source>Eur J Clin Nutr</source><year>2019</year><volume>73</volume><issue>1</issue><fpage>102</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/s41430-018-0260-5</pub-id><?supplied-pmid 30022117?><pub-id pub-id-type="pmid">30022117</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>JH</given-names></name><name><surname>Chung</surname><given-names>BY</given-names></name><name><surname>Kim</surname><given-names>HO</given-names></name><name><surname>Park</surname><given-names>CW</given-names></name></person-group><article-title>A histamine-free diet is helpful for treatment of adult patients with chronic spontaneous Urticaria</article-title><source>Ann Dermatol</source><year>2018</year><volume>30</volume><issue>2</issue><fpage>164</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.5021/ad.2018.30.2.164</pub-id><?supplied-pmid 29606813?><pub-id pub-id-type="pmid">29606813</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagernaes</surname><given-names>CF</given-names></name><name><surname>Heuch</surname><given-names>I</given-names></name><name><surname>Zwart</surname><given-names>JA</given-names></name><name><surname>Winsvold</surname><given-names>BS</given-names></name><name><surname>Linde</surname><given-names>M</given-names></name><name><surname>Hagen</surname><given-names>K</given-names></name></person-group><article-title>Blood pressure as a risk factor for headache and migraine: a prospective population-based study</article-title><source>Eur J Neurol</source><year>2015</year><volume>22</volume><issue>1</issue><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1111/ene.12547</pub-id><?supplied-pmid 25155744?><pub-id pub-id-type="pmid">25155744</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saneei</surname><given-names>P</given-names></name><name><surname>Salehi-Abargouei</surname><given-names>A</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name><name><surname>Azadbakht</surname><given-names>L</given-names></name></person-group><article-title>Influence of dietary approaches to stop hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials</article-title><source>Nutr Metabolism Cardiovasc Dis</source><year>2014</year><volume>24</volume><issue>12</issue><fpage>1253</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2014.06.008</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santo</surname><given-names>NG</given-names></name></person-group><article-title>Reduction of sodium intake is a prerequisite for preventing and curing high blood pressure in hypertensive patients - second part: guidelines</article-title><source>Curr Hypertens Rev</source><year>2014</year><volume>10</volume><issue>2</issue><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.2174/1573402111666141231124028</pub-id><?supplied-pmid 25549842?><pub-id pub-id-type="pmid">25549842</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaeem</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Dilli</surname><given-names>E</given-names></name></person-group><article-title>Headaches: a review of the role of dietary factors</article-title><source>Curr Neurol Neurosci Rep</source><year>2016</year><volume>16</volume><issue>11</issue><fpage>101</fpage><pub-id pub-id-type="doi">10.1007/s11910-016-0702-1</pub-id><?supplied-pmid 27714637?><pub-id pub-id-type="pmid">27714637</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="other">Mirzababaei A, Khorsha F, Togha M, Yekaninejad MS, Okhovat AA, Mirzaei K (2018) Associations between adherence to dietary approaches to stop hypertension (DASH) diet and migraine headache severity and duration among women. Nutr Neurosci:1&#x02013;8&#x000a0;[Epub ahead of print].&#x000a0;</mixed-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amer</surname><given-names>M</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name></person-group><article-title>Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-sodium clinical trial</article-title><source>BMJ Open</source><year>2014</year><volume>4</volume><issue>12</issue><fpage>e006671</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2014-006671</pub-id><?supplied-pmid 25500372?><pub-id pub-id-type="pmid">25500372</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name></person-group><article-title>Lower sodium intake and risk of headaches: results from the trial of nonpharmacologic interventions in the elderly</article-title><source>Am J Public Health</source><year>2016</year><volume>106</volume><issue>7</issue><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2016.303143</pub-id><?supplied-pmid 27077348?><pub-id pub-id-type="pmid">27077348</pub-id></element-citation></ref></ref-list></back></article>